JAK2 inhibitors for the treatment of myeloprolifertive disorders.

被引：2
|
作者：
Hood, John [1 ]
Cao, Jon [1 ]
Hanna, Ehab [1 ]
Lohse, Dan [1 ]
Mak, Chi Ching [1 ]
McPherson, Andrew [1 ]
Noronha, Glenn [1 ]
Renick, Joel [1 ]
Zheng, Binqi [1 ]
Zhu, Hong [1 ]
Soll, Richard [1 ]
机构：
[1] Res & Dev, San Diego, CA USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3632.3632
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3632
引用
收藏
页码：1038A / 1038A
页数：1
相关论文
共 50 条
  • [1] JAK2 kinase inhibitors and myeloproliferative disorders
    Chen, Andrew T.
    Prchal, Josef T.
    CURRENT OPINION IN HEMATOLOGY, 2010, 17 (02) : 110 - 116
  • [2] Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders
    Brasca, Maria Gabriella
    Gnocchi, Paola
    Nesi, Marcella
    Amboldi, Nadia
    Avanzi, Nilla
    Bertrand, Jay
    Bindi, Simona
    Canevari, Giulia
    Casero, Daniele
    Ciomei, Marina
    Colombo, Nicoletta
    Cribioli, Sabrina
    Fachin, Gabriele
    Felder, Eduard R.
    Galvani, Arturo
    Isacchi, Antonella
    Motto, Ilaria
    Panzeri, Achille
    Donati, Daniele
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (10) : 2387 - 2407
  • [3] SB1518: A potent and orally active JAK2 inhibitor for the treatment of myeloproliferative disorders.
    Goh, Kee C.
    Ong, Wai C.
    Hu, Changyong
    Hentze, Harries
    Liang, Ai L.
    Stunkel, Walter
    Tan, Yong C.
    Sangthongpitag, Kanda
    Goh, Siok K.
    Sieh, Shirly
    Bonday, Zahid Q.
    William, Anthony D.
    Lee, Angeline
    Llanchard, Stephanie
    Liu, Te C.
    Sattler, Martin
    Griffin, James D.
    Dymock, Brian W.
    Kantharaj, Ethirajulu
    Wood, Jeanette M.
    BLOOD, 2007, 110 (11) : 165A - 166A
  • [4] JAK2 INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Tefferi, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 20 - 21
  • [5] JAK2 inhibitors in the treatment of myeloproliferative neoplasms
    Tibes, Raoul
    Bogenberger, James M.
    Geyer, Holly L.
    Mesa, Ruben A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (12) : 1755 - 1774
  • [6] JAK2 inhibitors
    Hernandez Boluda, Juan Carlos
    Gomez, Montse
    Perez, Ariadna
    MEDICINA CLINICA, 2016, 147 (02): : 70 - 75
  • [7] Azepine inhibitors of JAK2
    Sparks, Richard B.
    Polam, Padmaja
    Arvinitis, Ari
    Rogers, James D.
    Liao, Boshan
    Covington, Maryanne
    Gallagher, Karen
    Caulder, Eian
    Shi, Jack
    Liu, Phillip C. C.
    Fridman, Jordan S.
    Scherle, Peggy A.
    Combs, Andrew P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [8] Setback for JAK2 inhibitors
    Mark Ratner
    Nature Biotechnology, 2014, 32 (2) : 119 - 119
  • [9] Myelofibrosis, JAK2 inhibitors and erythropoiesis
    Vainchenker, W.
    Favale, F.
    LEUKEMIA, 2013, 27 (06) : 1219 - 1223
  • [10] JAK2 Inhibitors: A Reality? A Hope?
    Apostolidou, Effrosyni
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S340 - S345
12345